Philip M Nussenzweig

200

100

150

201420152016201720182019202020212022202320247 36 71 94 109 120 122 173 197 174 52

Public access

4 articles

0 articles

available

not available

Based on funding mandates

Wenyan JiangAssistant Professor, Mount Sinai School of Medicine, Columbia University, Rockefeller UniversityVerified email at mssm.edu
Chad EulerHunter College, CUNYVerified email at hunter.cuny.edu
Gregory W GoldbergThe Rockefeller University, NYU Grossman School of MedicineVerified email at rockefeller.edu
Jon McGinnDamon Runyon Postdoctoral Fellow, MITVerified email at mit.edu

Philip M Nussenzweig

MD/PhD Student, Weill Cornell Medicine/Rockefeller University

Verified email at rockefeller.edu - Homepage


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials D Bikard, CW Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ... Nature biotechnology 32 (11), 1146-1150, 2014	920	2014
Molecular mechanisms of CRISPR-Cas immunity in bacteria PM Nussenzweig, LA Marraffini Annual Review of Genetics, 93-120, 2020	125	2020
Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases D Bikard, C Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ... Nature biotechnology 32 (11), 1146, 2014	64	2014
Cas9 Cleavage of Viral Genomes Primes the Acquisition of New Immunological Memories PM Nussenzweig, J McGinn, LA Marraffini Cell host & microbe 26 (4), 515-526. e6, 2019	54	2019
Viral Teamwork Pushes CRISPR to the Breaking Point PM Nussenzweig, LA Marraffini Cell 174 (4), 772-774, 2018	4	2018
Cas9-Primed Adaptive Immunity During the CRISPR-Cas Response PM Nussenzweig	1	2020

The system can't perform the operation now. Try again later.

Articles 1–6

Citations per year